Plasma adiponectin concentrations and risk of incident breast cancer.
暂无分享,去创建一个
W. Willett | G. Colditz | C. Mantzoros | S. Hankinson | T. Kelesidis | S. Tworoger | A. Eliassen | G. Colditz | Shelley S. Tworoger | Christos S. Mantzoros | Walter C. Willett
[1] T. Sørensen,et al. Growth patterns and the risk of breast cancer in women. , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[2] F. Clavel-Chapelon,et al. Serum C‐peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC) , 2006, International journal of cancer.
[3] C. Mantzoros,et al. Adiponectin: a link between obesity and cancer , 2006, Expert opinion on investigational drugs.
[4] M. Dieudonné,et al. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.
[5] M. Hou,et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. , 2006, Cancer letters.
[6] C. Mantzoros,et al. Adiponectin and cancer: a systematic review , 2006, British Journal of Cancer.
[7] S. Hankinson,et al. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. , 2006, Cancer research.
[8] W. Hanif,et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males , 2005, Diabetologia.
[9] W. Willett,et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study , 2005, Breast Cancer Research.
[10] B. Rosner,et al. Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer , 2004, Cancer Research.
[11] D. Rose,et al. Obesity, adipocytokines, and insulin resistance in breast cancer , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[12] Jami L. Johnson,et al. Effects of social status and moderate alcohol consumption on mammary gland and endometrium of surgically postmenopausal monkeys , 2004, Menopause.
[13] H. Adami,et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] J. Flier,et al. Adipose Tissue as an Endocrine Organ , 2014 .
[15] T. Bates,et al. Obesity and breast cancer: a review of the literature. , 2004, Breast.
[16] John A Wagner,et al. Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.
[17] C. Mantzoros,et al. Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.
[18] S. Kihara,et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Hoover,et al. Serum concentrations of IGF‐I, IGFBP‐3 and c‐peptide and risk of hyperplasia and cancer of the breast in postmenopausal women , 2004, International journal of cancer.
[20] X. Shu,et al. Evaluation of the synergistic effect of insulin resistance and insulin‐like growth factors on the risk of breast carcinoma , 2004, Cancer.
[21] R. Glynn,et al. Methods to evaluate risks for composite end points and their individual components. , 2004, Journal of clinical epidemiology.
[22] S. Kihara,et al. Association of serum adiponectin levels with breast cancer risk. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] P. Froguel,et al. Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.
[24] J. Chan,et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. , 2003, The Journal of clinical endocrinology and metabolism.
[25] S. Cummings,et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.
[26] E. Riboli,et al. Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer , 2003, International journal of cancer.
[27] H. Iwata,et al. Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. , 2003, Asian Pacific journal of cancer prevention : APJCP.
[28] JoAnn E Manson,et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. , 2003, Diabetes care.
[29] T. Saruta,et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.
[30] M. Latteri,et al. Metabolic syndrome and breast cancer risk. , 2002, European review for medical and pharmacological sciences.
[31] X. Shu,et al. Population-based, case-control study of blood C-peptide level and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[32] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[33] L. Tessitore,et al. Leptin expression in colorectal and breast cancer patients. , 2000, International journal of molecular medicine.
[34] E. Barrett-Connor,et al. Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo Study. , 1999, Journal of women's health & gender-based medicine.
[35] G. Colditz,et al. Adolescence and breast carcinoma risk , 1999, Cancer.
[36] J. Manson,et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. , 1999, Journal of the National Cancer Institute.
[37] J. Manson,et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.
[38] David J Hunter,et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.
[39] Z. Gucev,et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. , 1996, The international journal of biochemistry & cell biology.
[40] G A Colditz,et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. , 1995, Journal of the National Cancer Institute.
[41] A. A. Hart,et al. Insulin resistance and breast‐cancer risk , 1992, International journal of cancer.
[42] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[43] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[44] B. Rosner. Percentage Points for a Generalized ESD Many-Outlier Procedure , 1983 .
[45] O. Faber,et al. C-peptide Metabolism and the Liver , 1978, Diabetes.
[46] O. Miettinen,et al. Estimability and estimation in case-referent studies. , 1976, American journal of epidemiology.
[47] I. G. Fantus,et al. Insulin and related factors in premenopausal breast cancer risk , 2004, Breast Cancer Research and Treatment.